David Rosenthal

Pediatric cardiologist at Stanford Children’s Health

[David Rosenthal @RosenthalDN]

@Katrina88215142 @mgoschu @ACTION4HF Certainly a challenging population for multiple reasons. Approximately 1/2 of Fontan patients listed for tx have low EF and can probably be supported with existing VAD technology albeit with steep learning curve...

[David Rosenthal @RosenthalDN]

@AriCedars @ACTION4HF @mgoschu Do you think this is common amongst ACHD providers? #actionjc

[David Rosenthal @RosenthalDN]

@LortsAngie @ACTION4HF @mgoschu Seems like a good situation for collaborative QI with families and providers, right along lines that ACTION does well. #actionjc

[David Rosenthal @RosenthalDN]

@mgoschu @AuerbachScott @ACTION4HF Occlusion of the entire lymphatic system is pretty drastic. Surprising that it can even work although it sometimes seems to.

[David Rosenthal @RosenthalDN]

@AuerbachScott @ACTION4HF @mgoschu Really important point. Occlusion of the entire lymphatic system is a pretty drastic treatment and likely to have unintended consequences.

[David Rosenthal @RosenthalDN]

@ACTION4HF @mgoschu Lymphatic occlusion seems most effective for plastic bronchitis, where it can probably be “curative”. For PLE, occlusion seems more palliative, but can still be great as bridge to tx, or for symptom relief.

[David Rosenthal @RosenthalDN]

@ACTION4HF @mgoschu What do others in this thread think about these treatments? #actionjc

[David Rosenthal @RosenthalDN]

@ACTION4HF @mgoschu I am most impressed by the potential (and to a degree the reality) of lymphatic-oriented therapies, including occlusion and reimplantation. Not needed for everyone, but game changing in some cases. #actionjc

[David Rosenthal @RosenthalDN]

@ACTION4HF I’m here - just getting my feet on the ground with this format. #actionjc

[David Rosenthal @RosenthalDN]

@ACTION4HF @CircAHA Ready to jump in? First ACTION journal club. #actionjc